Optimizing the first-line fertility treatment

被引:4
|
作者
Irani, Mohamad [1 ]
Chow, Stephen [1 ]
Keating, Derek [1 ]
Elder, Simone [2 ]
Rosenwaks, Zev [1 ]
Palermo, Gianpiero [1 ]
机构
[1] Weill Cornell Med, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA
[2] Weill Cornell Med, New York, NY USA
关键词
Clomiphene citrate; endometrial thickness; follicle; intrauterine insemination; total motile spermatozoa; INTRAUTERINE INSEMINATION; SPERM MORPHOLOGY; ENDOMETRIAL THICKNESS; PREDICTIVE-VALUE; PREGNANCY; INFERTILITY; MANAGEMENT; PROGNOSIS; NUMBER; IUI;
D O I
10.1080/09513590.2018.1441825
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this study was to identify sperm score thresholds to achieve satisfactory intrauterine insemination (IUI) success rates according to the response to stimulation with clomiphene citrate (CC). To minimize the confounding effect of female age, we included only CC/IUI cycles of women 35years old. A total of 1,194CC/IUI cycles were included. Semen volume, concentration, and motility influenced the clinical pregnancy rate (CPR). Normal morphology (4%) was associated with a comparable CPR with 3%, 2%, and 1% normal forms (15.6%, 16.1%, 18.1%, and 13.1%, respectively). A combination of the total number of motile spermatozoa in the ejaculate before semen preparation (TM) at a threshold 20x10(6) was associated with a CPR of 17.8% compared to 4.6% for a threshold <20x10(6) (p<.001). Interestingly, the TM threshold to achieve satisfactory outcomes was lower (10x10(6)) in patients who had an optimal response to CC (2 dominant follicles with an endometrial thickness7mm) compared to 40x10(6) for those who had a suboptimal response (one dominant follicle with an endometrial thickness <7mm). In conclusion, the response to superovulation with CC determines each patient's TM threshold required for satisfactory outcomes. Couples whose TM is below the threshold may benefit from a superovulation with gonadotropins or in vitro fertilization.
引用
收藏
页码:742 / 746
页数:5
相关论文
共 50 条
  • [1] Optimizing the first-line treatment for metastatic colorectal cancer
    Cherri, Sara
    Oneda, Ester
    Zanotti, Laura
    Zaniboni, Alberto
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [2] Optimizing the first-line treatment for metastatic colorectal cancer
    Ciardiello, Davide
    Petrillo, Angelica
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [3] Optimizing first-line treatment options for patients with advanced NSCLC
    Wakelee, H
    Belani, CP
    ONCOLOGIST, 2005, 10 : 1 - 10
  • [4] Current research toward optimizing dosing of first-line antituberculosis treatment
    McIlleron, Helen
    Chirehwa, Maxwell T.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2019, 17 (01) : 27 - 38
  • [5] First-line achalasia treatment
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (03): : 180 - 180
  • [6] First-line treatment for hypertension
    Jackson, PR
    Ramsay, LE
    EUROPEAN HEART JOURNAL, 2002, 23 (03) : 179 - 182
  • [7] First-Line Treatment for Hypertension
    Chan, Stewart Siu-Wa
    Graham, Colin A.
    Rainer, Timothy Hudson
    JOURNAL OF CLINICAL HYPERTENSION, 2012, 14 (01): : 68 - 68
  • [8] First-Line Treatment for Hypertension
    Bui, Quynh
    AMERICAN FAMILY PHYSICIAN, 2010, 81 (11) : 1333 - 1335
  • [9] First-line treatment for BPH
    不详
    PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (03) : 200 - 200
  • [10] Optimizing first-line chemotherapy for metastatic colorectal cancer
    Adams, Richard A.
    COLORECTAL CANCER, 2012, 1 (03) : 241 - 253